Extended-Release Intramuscular Naltrexone: A Viewpoint by Steven Siegel

By Siegel Steven  

Drugs, Vol. 66, Iss. 13, 2006-01 ,pp. : 1752-1754

Adis International

Access to resources Recommend Favorite

Extended-Release Intramuscular Naltrexone in Alcohol Dependence in Adults: Profile Report

By Tracy Swainston Harrison   Plosker Greg L.   Keam Susan J.  

CNS Drugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 83-87

Adis International

Access to resources Recommend Favorite

Extended-Release Intramuscular Paliperidone Palmitate: A Review of its Use in the Treatment of Schizophrenia

By Carter Natalie J.  

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1137-1160

Adis International

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite